Senti Biosciences, Inc.

Healthcare · Biotechnology · United States

Last price 0.217 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 6.76M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Senti Biosciences Holdings, Inc., a clinical stage biotechnology company, develops cell and gene therapies engineered with its gene circuit platform technologies for patients living with incurable diseases. The company’s lead product candidates utilize off-the-shelf healthy adult donor derived natural killer (NK) cells to create CAR-NK cells outfitted with gene circuit technologies in various oncology indications with unmet need. It offers SENTI-202, a logic gated off-the-shelf CAR-NK cell therapy for the treatment of blood cancers and relapsed...